Ultravate PAC-Cream (Ranbaxy Laboratories Inc.)


Welcome to the PulseAid listing for the Ultravate PAC-Cream drug offered from Ranbaxy Laboratories Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ranbaxy Laboratories Inc.
NON-PROPRIETARY NAME: halobetasol propionate
SUBSTANCE NAME: HALOBETASOL PROPIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-02-10
END MARKETING DATE: 0000-00-00


Ultravate PAC-Cream HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltravate PAC-Cream from Ranbaxy Laboratories Inc.
LABELER NAME: Ranbaxy Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.5(mg/g)
START MARKETING DATE: 2010-02-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10631-113_54c3cb61-1c22-414a-9388-51fbec1dd826
PRODUCT NDC: 10631-113
APPLICATION NUMBER: NDA019967

Other HALOBETASOL PROPIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc.Halobetasol Propionate
G&W Laboratories, Inc.Halobetasol Propionate
H.J. Harkins Company, Inc.Halobetasol Propionate
Perrigo New York IncHalobetasol Propionate
Physicians Total Care, Inc.Halobetasol Propionate
Ranbaxy Laboratories Inc.Ultravate
Ranbaxy Laboratories, Inc.Ultravate
Rebel Distributors CorpHalobetasol Propionate
Taro Pharmaceuticals U.S.A., Inc.Halobetasol Propionate